EP4371553A1 — Composition comprising rocuronium
Assigned to B Braun Melsungen AG · Expires 2024-05-22 · 2y expired
What this patent protects
The present invention relates to a pharmaceutical composition comprising a pharmaceutically acceptable salt of rocuronium, at least one stabilizer, optionally a tonicity agent, and water, as well as to a method of manufacturing said pharmaceutical composition, and a container com…
USPTO Abstract
The present invention relates to a pharmaceutical composition comprising a pharmaceutically acceptable salt of rocuronium, at least one stabilizer, optionally a tonicity agent, and water, as well as to a method of manufacturing said pharmaceutical composition, and a container comprising said pharmaceutical composition.
Drugs covered by this patent
- Rocuronium (Rocuronium Bromide) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.